EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of E3 Ubiquitin Ligases Associated with Survival in Soft Tissue Sarcomas

Zackary Bender, Hannah C Beird iD, Peter Larsen, Gary S Coombs iD

International Journal of Molecular Sciences · 17.07.2026 · 27 (14) · 6350

DOI: 10.3390/ijms27146350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2026. Verfasst von Zackary Bender und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Waldorf University, 106 South 6th Street, Forest City, IA 50436, USA. Hauptthemen laut MEDLINE: Sarcoma, Ubiquitin-Protein Ligases. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteasome inhibitors are approved to treat multiple myeloma and mantle cell lymphoma. Recent reports suggest sarcomas also display proteasome addiction. Mechanistic explanations cite proteotoxic stress. In sarcoma patients, we analyzed the impacts of 377 human E3 ubiquitin ligases on sarcoma patient overall survival (OS) and recurrence-free survival (RFS), identified substrates of E3 ligases with the most significant and robust effects, and performed enrichment analyses. High expression of 102 E3 ligases was associated with shortened OS. Thirteen of these shortened OS by >40 months, six with false-discovery rates (FDR) ≤ 5%. Nineteen showed correlation between increased expression and shortened RFS, two with FDR ≤ 5%. Overexpression of 73 E3 ligases significantly extended OS, with 18 extending OS by >40 months; six with FDR ≤ 5%. Elevated expression of 21 significantly extended RFS, one with FDR ≤ 5%. Enrichment analyses of substrates unique to the E3 ligases whose elevated expression most reliably shortened or extended OS by >40 months revealed non-overlapping functions: the E3 ligases associated with shortened OS uniquely targeted cell cycle, cell–cell communication, cellular responses to stimuli, chromatin organization, DNA repair, DNA replication, hemostasis, reproduction, and vesicle-mediated transport functions. Both OS-impacting E3 ligase sets targeted developmental biology, gene expression, immune system, metabolism of proteins, and signal transduction functions. Three specific functions were targeted by both groups. Functions uniquely targeted by each set of ligases could reveal therapeutic targets with a greater therapeutic index than the proteasome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaUbiquitin-Protein LigasesHumansGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

BCR regulationE3 ubiquitin ligaseHUSH complexSIRT1chromosome condensationtelomere end packaging

Substanzen

Ubiquitin-Protein Ligases

Autor:innen und Institutionen

  • Biology Department, Waldorf University, 106 South 6th Street, Forest City, IA 50436, USA.
  • Department of Genomic Medicine, The University of Texas, UT MD Anderson Cancer Center, 1881 East Road, Houston, TX 77054, USA.
  • MercyOne North Iowa Medical Center, 1000 4th Street SW, Mason City, IA 50401, USA.

ORCID-Profile: Hannah C Beird, Gary S Coombs

Zitieren

APA

Bender, Z., Beird, H. C., Larsen, P., & Coombs, G. S. (2026). Identification of E3 Ubiquitin Ligases Associated with Survival in Soft Tissue Sarcomas. International Journal of Molecular Sciences, 27(14), 6350. https://doi.org/10.3390/ijms27146350

Vancouver

Bender Z, Beird HC, Larsen P, Coombs GS. Identification of E3 Ubiquitin Ligases Associated with Survival in Soft Tissue Sarcomas. International Journal of Molecular Sciences. 2026;27(14):6350. doi:10.3390/ijms27146350

BibTeX
@article{Bender2026,
  author = {Bender, Zackary and Beird, Hannah C and Larsen, Peter and Coombs, Gary S},
  title = {Identification of E3 Ubiquitin Ligases Associated with Survival in Soft Tissue Sarcomas},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6350},
  doi = {10.3390/ijms27146350}
}
Kostenlos starten →